ParoxetineThird Party Manufacturing in India

Paroxetine is a selective serotonin reuptake inhibitor (SSRI) that exerts its antidepressant and anxiolytic effects primarily by blocking the serotonin reuptake transporter (SERT) located on presynaptic neuronal membranes. By competitively inhibiting SERT, paroxetine prevents the reuptake of serotonin from the synaptic cleft back into the presynaptic neuron, thereby increasing extracellular serotonin concentrations and enhancing serotonergic neurotransmission. Among all SSRIs, paroxetine exhibits the highest known binding affinity for the central site of SERT, with an equilibrium dissociation constant in the picomolar range. This potent inhibition results in downregulation of upregulated postsynaptic serotonin receptors, which is thought to underlie its therapeutic effects in mood and anxiety disorders.

At higher doses exceeding 40 mg daily, paroxetine also demonstrates clinically significant inhibition of the norepinephrine transporter, contributing to its noradrenergic effects. It displays weak anticholinergic activity through minor affinity for muscarinic receptors, which may contribute to its more rapid onset of anxiolytic action compared to other SSRIs but also to side effects such as dry mouth and constipation. Paroxetine is a potent inhibitor of CYP2D6, leading to nonlinear pharmacokinetics where small dose increases can produce disproportionate rises in plasma concentration. This CYP2D6 inhibition also creates potential for drug-drug interactions with co-administered medications metabolized through this pathway. Compared to other SSRIs, paroxetine has a shorter half-life of approximately 21 hours, which necessitates careful dose tapering upon discontinuation to avoid withdrawal symptoms.

Therapeutic Uses

Paroxetine is prescribed for the treatment of:

• Major Depressive Disorder: Paroxetine is indicated for the treatment of depression in adults. It is effective in improving mood, restoring interest in daily activities, and reducing anxiety symptoms commonly associated with depressive episodes.

• Obsessive-Compulsive Disorder (OCD): Paroxetine is approved for the management of OCD in adults, helping reduce the frequency and intensity of obsessions and compulsions through its potent serotonergic activity.

• Panic Disorder: Paroxetine is effective in reducing the frequency and severity of panic attacks, with or without agoraphobia, and is one of the most commonly prescribed SSRIs for this indication.

• Social Anxiety Disorder (Social Phobia): Paroxetine is indicated for the treatment of social anxiety disorder, helping patients manage intense fear and avoidance of social performance situations.

• Generalized Anxiety Disorder (GAD): Paroxetine provides significant reduction in excessive worry, restlessness, muscle tension, and other somatic symptoms associated with GAD.

• Post-Traumatic Stress Disorder (PTSD): Paroxetine is approved for the treatment of PTSD, reducing intrusive thoughts, avoidance behaviors, and hyperarousal symptoms.

• Premenstrual Dysphoric Disorder (PMDD): Paroxetine is used for the treatment of PMDD and for managing vasomotor symptoms such as hot flashes and night sweats associated with menopause.

Why Manufacturers Choose Paroxetine

Paroxetine is among the most widely prescribed SSRIs globally with consistent demand across regulated and emerging markets. Indian pharmaceutical manufacturers produce paroxetine tablets and extended-release formulations for both domestic PCD franchise networks and export markets including the US, UK, Europe, and the Middle East. The molecule offers manufacturers multiple formulation opportunities, including immediate-release and controlled-release tablets in a range of strengths. With the growing global burden of depression and anxiety disorders, demand for cost-effective generic paroxetine continues to rise. Indian manufacturers with WHO-GMP certified facilities are well-positioned to serve this demand through third party manufacturing arrangements, offering competitive pricing and reliable supply to PCD franchise partners and export distributors worldwide.